Jasper Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:JSPR Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
08 Feb 24	BuyUS$4,532,500	Velan Capital Partners LP	Company	350,000	US$12.95
08 Feb 24	BuyUS$2,460,500	Abingworth LLP	Company	190,000	US$12.95
28 Nov 23	BuyUS$6,486	Thomas Wiggans	Individual	1,000	US$6.49

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of JSPR?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	191,545	1.24%
Hedge Funds	1,343,665	8.72%
VC/PE Firms	3,428,981	22.3%
Institutions	10,437,771	67.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 34.5%.

Top Shareholders

Top 25 shareholders own 92.04% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.56%	Velan Capital Partners LP	1,433,828	US$31.6m	-2.59%	33.27%
8.96%	Soleus Capital Management, L.P.	1,343,665	US$29.6m	5.29%	2.13%
7.11%	Abingworth LLP	1,066,189	US$23.5m	0%	16.5%
6.19%	Qiming Weichuang Venture Capital Management (Shanghai) Company Limited	928,964	US$20.5m	0%	1.38%
5.33%	BlackRock, Inc.	800,028	US$17.6m	15.5%	no data
4.63%	The Vanguard Group, Inc.	694,425	US$15.3m	0.63%	no data
3.9%	Samsara BioCapital LLC	584,642	US$12.9m	11.4%	1.86%
3.88%	Polar Capital Holdings Plc	581,538	US$12.8m	0%	0.05%
3.86%	Franklin Resources, Inc.	579,636	US$12.8m	-17%	no data
3.77%	Morgan Stanley, Investment Banking and Brokerage Investments	565,112	US$12.5m	83.2%	no data
3.31%	Kingdon Capital Management, L.L.C.	497,000	US$11.0m	0%	1.57%
3.3%	Woodline Partners LP	495,104	US$10.9m	19.6%	0.09%
3.22%	Braidwell LP	483,300	US$10.7m	0%	0.46%
3.06%	Rock Springs Capital Management LP	459,088	US$10.1m	13.5%	0.33%
2.66%	Ally Bridge Group	399,466	US$8.8m	82.7%	3.15%
2.36%	Opaleye Management Inc.	353,500	US$7.8m	-9.82%	1.19%
2.33%	Tavistock Life Sciences	350,000	US$7.7m	0%	0.49%
2.33%	Integral Health Asset Management, LLC	350,000	US$7.7m	0%	0.89%
2.17%	Bank of America Corporation, Asset Management Arm	325,881	US$7.2m	0.17%	no data
2.15%	Great Point Partners, LLC	322,380	US$7.1m	-19.8%	2.54%
1.76%	HBM Partners Ltd.	264,000	US$5.8m	0%	0.6%
1.72%	Geode Capital Management, LLC	257,416	US$5.7m	-0.9%	no data
1.64%	Avego Healthcare Capital, LLC	245,328	US$5.4m	0%	100.0%
1.43%	State Street Global Advisors, Inc.	214,883	US$4.7m	12.3%	no data
1.41%	Russell Investment Management, LLC	211,526	US$4.7m	49.5%	0.01%